Molecular biology studies have demonstrated that BC can be divided into the following four subtypes based on the expression of specific molecular markers: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative BC subtypes (3). The gene discussed is ERBB2; the disease is breast cancer.